Cardiometabolic Disease

Disease

Type 2 Diabetes

Chronic metabolic disease of insulin resistance and relative insulin deficiency; accounts for ~90-95% of diagnosed diabetes cases in the US.

Total attributable cost

$324.6B

$12,022/patient

Drug spend

$126.1B

$4,670/patient

How this is calculated ↗

39% of total cost is drugs

All severities · US

All assets in Type 2 Diabetes

Cardiometabolic Disease